ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Anti-Ageing
Approved

Thymosin Alpha-1

Thymosin Alpha-1

Also known as: Ta1, Zadaxin, Thymalfasin

Overview

Key Facts

Primary Goal: A 28-amino acid peptide originally isolated from thymic tissue by Allan Goldstein in the 1970s

A 28-amino acid peptide originally isolated from thymic tissue by Allan Goldstein in the 1970s. FDA orphan drug and approved in over 35 countries for hepatitis B/C and as an immune adjuvant. Considered the gold standard immune-modulating peptide. Half-Life ~2 hours Typical Dose 1.6–3.2 mg Frequency 2x per week Cycle Length 8-12 weeks, may be used long-term under medical supervision

Dosing Information

Half-Life

~2 hours

Typical Dose

1.6–3.2 mg

Frequency

2x per week

Cycle Length

8-12 weeks, may be used long-term under medical supervision

Administration Routes:

subcutaneous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Approved
3 studies

Approved in over 35 countries for chronic hepatitis B/C and as a vaccine adjuvant. Granted FDA orphan drug designation. Extensive clinical trial data including Phase 3 studies in hepatitis and Phase 2 studies as cancer immunotherapy adjunct. SciClone Pharmaceuticals conducted large-scale RCTs demonstrating improved viral clearance and immune reconstitution.

Frequently Asked Questions

Common questions about Thymosin Alpha-1

UK-Specific Information

Exclusive data points and guidance for UK residents using Thymosin Alpha-1

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With